Sylvie Opatrná

Pharmacokinetics and Pharmacodynamics of Intravenous and Subcutaneous Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Chronic Kidney Disease

Iain C. Macdougall, Richard A. Robson, Sylvie Opatrná et al. · Clinical Journal of the American Society of Nephrology · 2006 · 188 citations

Hemodialysis, Urology, Renal Function +14

Cell‐Free Plasma DNA during Peritoneal Dialysis and Hemodialysis and in Patients with Chronic Kidney Disease

Marie Korabečná, Sylvie Opatrná, Jan Wirth et al. · Annals of the New York Academy of Sciences · 2008 · 58 citations

Negative association between plasma levels of adiponectin and polychlorinated biphenyl 153 in obese women under non-energy-restrictive regime

Dana Müllerová, Ján Kopecký, Dagmar Matějková et al. · International Journal of Obesity · 2008 · 36 citations

Obesity, Metabolic Syndrome, Health Sciences +11

Procalcitonin Levels in Peritoneal Dialysis Patients

Sylvie Opatrná, Jan Klaboch, K Opatrný et al. · Peritoneal Dialysis International · 2005 · 36 citations

Determinants of prevalent vertebral fractures and progressive bone loss in long-term hemodialysis patients

Jan Mareš, Kristina Ohlidalova, Sylvie Opatrná et al. · Journal of Bone and Mineral Metabolism · 2009 · 30 citations

Bone Disease, Skeletal Trauma, Hemodialysis +11